Physician profile
Gerald I Cohen
NPI 1396731527
$9,156.67
in general payments reported to CMS, 2019-2025
19 companies · $316 in 2025
The $316 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,116 · 2020: $119 · 2021: $1,837 · 2022: $191 · 2023: $788 · 2024: $791 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,327 · Travel and Lodging: $567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,326.69 |
| Travel and Lodging | $567.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $4,489.41 | 2019 | |
| Ge Healthcare | $1,726.00 | 2021 | |
| Medtronic, INC. | $904.76 | 2023-2025 | Corevalve Evolut R, Apollotm |
| Edwards Lifesciences Corporation | $493.17 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $348.65 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $239.50 | 2019-2025 | Camzyos |
| Medtronic Vascular, INC. | $233.81 | 2019 | |
| Shockwave Medical, INC | $182.01 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Actelion Pharmaceuticals US, INC. | $122.03 | 2022 | |
| Pfizer INC. | $119.65 | 2023-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $60.67 | 2019-2022 | |
| Abiomed | $50.91 | 2025 | |
| Janssen Pharmaceuticals, INC | $42.33 | 2019-2024 | Xarelto |
| Amgen INC. | $41.73 | 2019-2024 | Repatha |
| Chiesi USA, INC. | $36.31 | 2024 | Kengreal, Cleviprex |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $19.84 | 2024 | (R13) Epiq Cvx |
| Kestra Medical Technology Services, INC. | $17.74 | 2024 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $14.60 | 2019 | |
| Biosense Webster, INC. | $13.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.